These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34953730)

  • 1. Opioid risk screening: Program evaluation from the community pharmacists' perspective.
    Frenzel O; Eukel H; Lothspeich E; Skoy E; Steig J; Strand M; Werremeyer A
    J Am Pharm Assoc (2003); 2022; 62(3):859-863.e1. PubMed ID: 34953730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose.
    Skoy E; Eukel H; Werremeyer A; Strand M; Frenzel O; Steig J
    J Am Pharm Assoc (2003); 2020; 60(1):117-121. PubMed ID: 31677933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.
    Strand MA; Eukel H; Burck S
    Res Social Adm Pharm; 2019 Aug; 15(8):1032-1036. PubMed ID: 30031696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose.
    Skoy E; Werremeyer A; Steig J; Eukel H; Frenzel O; Strand M
    Subst Abus; 2021; 42(4):672-677. PubMed ID: 33044896
    [No Abstract]   [Full Text] [Related]  

  • 5. Program evaluation of the Opioid and Naloxone Education (ONE Rx) program using the RE-AIM model.
    Strand MA; Eukel H; Frenzel O; Skoy E; Steig J; Werremeyer A
    Res Social Adm Pharm; 2020 Sep; 16(9):1248-1254. PubMed ID: 31812501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Pharmacists' Perceptions After a Training in Opioid Misuse and Accidental Overdose Prevention.
    Eukel HN; Skoy E; Werremeyer A; Burck S; Strand M
    J Contin Educ Health Prof; 2019; 39(1):7-12. PubMed ID: 30614959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Community Pharmacist-Delivered Care for Patients With Psychiatric Disorders Filling an Opioid Prescription.
    Werremeyer A; Frenzel O; Strand MA; Eukel H; Skoy E; Steig J
    Psychiatr Serv; 2022 Nov; 73(11):1294-1297. PubMed ID: 35502518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies.
    Rao D; Ford JH; Shiyanbola OO
    Addict Sci Clin Pract; 2024 Apr; 19(1):27. PubMed ID: 38589965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental Overdose.
    Skoy E; Frenzel O; Eukel H; Lothspeich E; Steig J; Strand M; Werremeyer A
    Prev Chronic Dis; 2022 Jul; 19():E41. PubMed ID: 35834737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
    Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A
    Res Social Adm Pharm; 2019 Aug; 15(8):1047-1055. PubMed ID: 30396825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacist-provided opioid intervention frequencies and barriers.
    Nichols MA; Kepley KL; Rosko KS; Hudmon KS; Curran GM; Ott CA; Snyder ME; Miller ML
    J Am Pharm Assoc (2003); 2023; 63(1):336-342. PubMed ID: 36369075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
    Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
    J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Student pharmacists' attitudes, perceptions, and knowledge regarding opioid use, misuse, and overdose: Four years of data.
    Murnane KS; Augustine JM; Marshall LL
    Curr Pharm Teach Learn; 2022 Oct; 14(10):1222-1228. PubMed ID: 36283793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Misuse and Overdose: Changes in Pharmacist Practices and Outcomes.
    Eukel H; Steig J; Frenzel O; Skoy E; Werremeyer A; Strand M
    J Contin Educ Health Prof; 2020; 40(4):242-247. PubMed ID: 33284175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The gatekeepers in prevention": Community pharmacist perceptions of their role in the opioid epidemic.
    Vadiei N; Eldridge LA; Meyerson BE; Agley J
    Subst Abus; 2022; 43(1):319-327. PubMed ID: 34214407
    [No Abstract]   [Full Text] [Related]  

  • 18. Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis.
    Salwan A; Hagemeier NE; Tudiver F; Dowling-McClay K; Foster KN; Arnold J; Alamian A; Pack RP
    J Am Pharm Assoc (2003); 2020; 60(6):e173-e178. PubMed ID: 32669219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implementation of a naloxone rescue program in university students.
    Panther SG; Bray BS; White JR
    J Am Pharm Assoc (2003); 2017; 57(2S):S107-S112.e2. PubMed ID: 28063773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community Pharmacists' Perspectives on Dispensing Medications With the Potential for Misuse, Diversion, and Intentional Overdose: Results of a Province-Wide Survey of Community Pharmacists in Canada.
    Leong C; Alessi-Severini S; Sareen J; Enns MW; Bolton J
    Subst Use Misuse; 2016 Nov; 51(13):1724-30. PubMed ID: 27487323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.